Mogana Das Murtey | Cancer Cell Biology | Best Researcher Award

Dr. Mogana Das Murtey | Cancer Cell Biology | Best Researcher Award

Dr. Mogana Das Murtey , Universiti Sains Malaysia , Malaysia

Dr. Mogana Das Murtey is a Senior University Lecturer at Universiti Sains Malaysia (USM), with extensive expertise in cancer biology, microscopy, and toxicology. She holds a Ph.D. in Molecular and Cellular Biology from USM, where she also earned her Master of Science in Pathology. With more than a decade of teaching experience, Dr. Murtey has contributed significantly to scientific research and education. Her research has focused on cancer prevention, particularly through natural products, and includes groundbreaking studies in toxicology and microscopy techniques. She is a committed mentor and has published extensively in international journals, with multiple awards for her innovative contributions to science. She is an active member of various professional organizations, including the Royal Microscopy Society (UK), and regularly serves as a reviewer for leading journals. Dr. Murtey is dedicated to advancing scientific knowledge in the fields of cancer research and microscopy.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Experience:

    • Dr. Murtey has significant experience in cancer biology, microscopy, and toxicology, with notable contributions to these fields. His research is regularly published in peer-reviewed journals, such as the Journal of Oncology, Asian Pacific Journal of Cancer Prevention, and Oxidative Medicine and Cellular Longevity.
    • He has contributed as both first and corresponding author in reputable journals, demonstrating leadership and a high level of responsibility in his research endeavors.
    • His work spans multiple cancer types, including breast cancer, cervical cancer, and salivary gland carcinoma, showing both depth and breadth in his research areas.
  2. Innovative Approaches in Cancer Chemoprevention:

    • Dr. Murtey has worked on several groundbreaking studies, particularly in the area of natural product chemoprevention, such as using paddy husk and other plant-based materials to fight cancer. His research could potentially impact public health by offering new, cost-effective cancer treatments or prevention strategies.
    • He has intellectual property (copyright) for novel techniques, including immunogold techniques for scanning electron microscopy, showcasing his contribution to advancing scientific methods.
  3. Teaching and Mentorship:

    • As a Senior University Lecturer, Dr. Murtey has a strong commitment to teaching, having taught a variety of courses in oral biology, histology, and medical sciences, mentoring the next generation of scientists.
    • He has been an academic leader, holding positions like course coordinator and serving on multiple committees within his institution, further highlighting his administrative and leadership qualities.
  4. Recognition and Awards:

    • He has been recognized for his innovative research, including winning gold medals for his work on prostate disease chemoprevention and other health-related innovations.
    • His consistent recognition in prestigious events and competitions reflects the high regard in which his work is held by peers and experts in the field.
  5. Research Grants:

    • Dr. Murtey has secured significant research funding, including bridging and short-term grants from Universiti Sains Malaysia, for projects that involve cutting-edge research on cancer prevention and treatment.
  6. International Collaboration and Publication:

    • His research has international reach, evidenced by publications in global journals and his participation in conferences and symposiums. Furthermore, he serves as a reviewer for multiple respected journals, adding to his credibility and influence within the academic community.

Areas for Improvement:

  1. Increased Focus on Collaborative Research:

    • While Dr. Murtey has a strong individual publication record, more large-scale collaborative projects or multi-disciplinary research could further enhance his impact, particularly in advancing the translation of his findings into clinical or public health applications.
  2. Broader Outreach and Impact:

    • His work, although recognized in academia, could benefit from a stronger outreach strategy aimed at translating his findings into broader societal benefits. This could include partnerships with industry, public health organizations, or policymakers to implement his research at a larger scale.
  3. Grant Diversification:

    • Expanding beyond institutional and national grants to attract more international or industry-backed funding could further solidify his position as a global leader in his field. Additionally, incorporating more collaborative grants with researchers across different fields or industries may provide more extensive funding opportunities.

Education:

Dr. Mogana Das Murtey pursued her academic journey at Universiti Sains Malaysia (USM), where she completed her Ph.D. in Molecular and Cellular Biology (2013-2018). Her research focused on cancer biology and cellular mechanisms, making significant contributions to the understanding of cancer prevention. Prior to her doctoral studies, Dr. Murtey earned a Master of Science in Pathology from USM (2009-2013), where she specialized in understanding diseases at the cellular and molecular levels. She also holds a Bachelor’s degree in Biomedicine (Honours) from Management and Science University (2005-2009), where she first developed her passion for biomedical sciences. Dr. Murtey’s educational background has provided her with a solid foundation in both the theoretical and practical aspects of biomedical research, and she has continually applied her knowledge through teaching, mentoring, and extensive research in her field.

Experience:

Dr. Mogana Das Murtey has over a decade of teaching and research experience in the field of molecular and cellular biology. She is a Senior University Lecturer at Universiti Sains Malaysia (USM), where she has been since 2019. Throughout her career, Dr. Murtey has taught a variety of pathology and oncology-related courses, including Oral Biology, Oral Histology, and Basic Medical Sciences. Her role also includes supervising research projects at both the undergraduate and graduate levels. Before her current position, Dr. Murtey taught part-time at several institutions, including Sultan Abdul Halim Muadzam Shah International Islamic University and Allianze University College of Medical Sciences. In addition to her academic roles, she has been an active researcher, publishing numerous articles in peer-reviewed journals and contributing to groundbreaking work in cancer research and toxicology. Her work has led to several prestigious research grants and collaborations both locally and internationally.

Awards and Honors:

Dr. Mogana Das Murtey has been recognized with multiple awards for her innovative contributions to science. She won the Art Science Competition 2023 organized by the School of Medical Sciences, USM, for her outstanding scientific innovation. She also received a Gold Medal for her research on the chemopreventive agent “Pamentm: New Chemopreventive Agent for Prostate Disease” at the SIRIM Invention, Innovation & Technology Expo 2022. Additionally, Dr. Murtey received the Gold Medal at the Virtual International Research and Innovation Symposium and Exhibition (RISE 2021) at Universiti Tun Hussein Onn Malaysia. Her work has been acknowledged for its impact on advancing cancer research, particularly in cancer prevention through natural products. These awards reflect her commitment to excellence in research and innovation. Dr. Murtey’s achievements underscore her leadership in the academic and research communities.

Research Focus:

Dr. Mogana Das Murtey’s research primarily focuses on cancer biology, toxicology, and microscopy, with a special emphasis on the chemopreventive potential of natural products. Her research aims to identify new ways to prevent and treat various types of cancer, particularly through the use of natural compounds. She has been involved in groundbreaking studies on the pharmacological potentials of paddy waste products, such as husk and straw, in preventing cancer. Dr. Murtey’s work also includes exploring the role of microscopy techniques, such as scanning electron microscopy and immunogold labeling, to study cellular structures in detail. She has also contributed significantly to the understanding of toxicological effects and how certain substances impact cellular function. Her research has been widely published, and she continues to lead projects that explore the intersection of molecular biology, cancer prevention, and environmental science.

Publication Top Notes:

  1. Chemopreventive Potential of Paddy Waste: A Promising Approach Against Benign Prostate Hyperplasia in Spontaneously Hypertensive Rats 🌾💡
  2. Chemoprevention of Natural Products Against Oral Cancer: A Comprehensive Review 🍃🦷
  3. Negative Staining: Forgotten Technique in Microbiology 🧫🔬
  4. Chemopreventive Activity of Two Varieties of Freeze-Dried Coconut Water Against Cervical Cancer Cells, HeLa 🥥🧪
  5. Evaluation of Effect of Honey Sugars Analogue Therapy Against Breast Cancer Induced by 1-Methyl-1-Nitrosourea in In Vivo Breast Cancer Model 🍯🎗️
  6. Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial 💊🔬
  7. Development of Myocardial Infarction in Rat Model of Diet-Induced Hypercholesterolemia 🐀💔
  8. Gliclazide in Binary and Ternary Systems Improves Physicochemical Properties, Bioactivity, and Antioxidant Activity 💊🌿
  9. Life Science Sample Preparations for Scanning Electron Microscopy 🔬💡
  10. The Phytochemical Analysis and Pharmacological Potentials of Husk and Straw as Paddy Waste Products 🌾🍃

Conclusion:

Dr. Mogana Das Murtey is an exemplary candidate for the “Best Researcher Award” due to his profound contributions to cancer biology, particularly in the areas of chemoprevention and innovative microscopy techniques. His extensive publication record, innovative research methodologies, intellectual property contributions, and recognition from peers and institutions provide compelling evidence of his excellence. While there are areas where increased collaboration and broader outreach could further enhance his career, his consistent track record of success and leadership in both research and teaching positions him as a strong contender for the award.

Iwona Kwiecień | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Iwona Kwiecień | Cancer Cell Biology | Best Researcher Award

Assist. Prof. Dr. Iwona Kwiecień , Military Institute of Medicine – National Research Institute , Poland

Iwona Kwiecień, PhD, is an expert in clinical immunology and laboratory medicine. With a strong academic background and extensive experience in medical research, she has dedicated her career to exploring immunological mechanisms in various diseases. She is currently working at the Military Institute of Medicine in Warsaw, where she serves as a lab specialist and lecturer. Dr. Kwiecień holds a PhD in Medical Science with a specialization in immunology from the Medical University of Warsaw. Her research focuses on the immune response in lung cancer, sarcoidosis, and other inflammatory diseases, employing advanced techniques such as multicolor flow cytometry. Her scientific contributions have been recognized globally, and she continues to shape the field of immunology through her research and teaching.

Publication Profile:

Scopus

Strengths for the Award:

Dr. Iwona Kwiecień possesses an impressive academic background and a consistent record of significant contributions to the field of immunology and medical research. With a Ph.D. in Medical Science and immunology, along with expertise in laboratory medicine, hematology, and flow cytometry, Dr. Kwiecień has shown remarkable skill in investigating the immune system’s role in lung cancer and other diseases. Her work on antigenic profiles in the lung cancer microenvironment, macrophage subpopulations in lung cancer, and immune responses in systemic inflammation highlights her strong research abilities. The 2024 habilitation diploma is a testament to her research excellence. Furthermore, Dr. Kwiecień has contributed to the publication of numerous peer-reviewed articles with significant citations and impact, indicating her strong presence in the scientific community.

Areas for Improvement:

While Dr. Kwiecień has demonstrated significant strength in immunological research, expanding her focus to include other cancer types or diseases beyond lung cancer may broaden the scope of her impact. Additionally, fostering greater international collaboration could further enhance the dissemination of her research globally.

Education:

Iwona Kwiecień earned her Master of Science in Laboratory Medicine from the Medical University of Warsaw in 2012. Later, she completed her PhD at the same university’s First Faculty of Medicine, specializing in immunology, with a thesis on regulatory mechanisms of the immune response, which she defended in 2017. She further pursued a specialization in Laboratory Medical Hematology at the Medical University of Silesia in Katowice, Poland, completing it in 2021. Dr. Kwiecień is also set to receive her habilitation diploma from the Military Institute of Medicine-National Research Institute in 2024, based on her scientific achievements in lung cancer immunology. Throughout her academic journey, she has developed expertise in clinical cytology, flow cytometry, and immunological assays, contributing significantly to the scientific community.

Experience:

Dr. Iwona Kwiecień has accumulated substantial experience in the field of laboratory medicine and immunology, working at several prestigious institutions. Since 2017, she has been a laboratory specialist and lecturer at the Military Institute of Medicine-National Research Institute in Warsaw, focusing on flow cytometry and hematology. Her role involves designing, performing, and analyzing complex experiments, as well as providing education and training to students. Prior to her current position, Dr. Kwiecień worked as a research coordinator assistant at BioVirtus Research Site and Clinical Research Group in Warsaw. Her academic career also includes time spent at the University Clinical Center of the Medical University of Warsaw, where she collaborated on various pathology and immunology projects. Dr. Kwiecień’s professional experience extends to overseeing numerous grants and research projects, including her work on macrophage subpopulations and lung cancer.

Awards and Honors:

Dr. Iwona Kwiecień has received several accolades in recognition of her outstanding contributions to science and research. Among her awards is the prestigious “Gold Laurel Graduate” medal for being the best graduate of Laboratory Medicine at the Medical University of Warsaw in 2013. She also received the 2nd award from the Polish Archives of Internal Medicine for her student research on macrophage subpopulations in sarcoidosis in 2014. Additionally, Dr. Kwiecień has been the recipient of numerous research grants, including the 2014-2015 Grant for Young Scientific Researcher from the Medical University of Warsaw. Her work on macrophage subpopulations in lung cancer earned her a statutory grant at the Military Institute of Medicine in 2018-2019. These awards reflect her exceptional research contributions and commitment to advancing the field of clinical immunology and laboratory medicine.

Research Focus:

Dr. Iwona Kwiecień’s research focus lies primarily in the immunology of lung cancer, sarcoidosis, and inflammatory diseases. Her studies have explored immune responses, particularly the role of macrophages, regulatory T cells, and other immune cell populations in disease progression. A key area of her research involves the use of multicolor flow cytometry to assess antigenic profiles of cells in cancer microenvironments. She has contributed to the understanding of how immune cells, such as T cells and macrophages, interact with tumor cells in the context of lung cancer and other inflammatory conditions. Dr. Kwiecień has also researched the impact of systemic inflammation on diseases like obstructive sleep apnea. Her work aims to uncover novel therapeutic targets and provide insights into the immune mechanisms driving various pathologies. Through her research, Dr. Kwiecień continues to contribute valuable knowledge to the fields of clinical immunology and hematology.

Publications Top Notes:

  1. Frequency and spontaneous cytotoxicity of natural killer cells in healthy children: preliminary results 🧬🧒
  2. Association between M1 and M2 macrophages in bronchoalveolar lavage fluid and tobacco smoking in patients with sarcoidosis 💨🫁
  3. Cytometric analysis of perforin expression in NK cells, CD8+, and CD4+ lymphocytes in children with autoimmune Hashimoto’s thyroiditis 👶🦠
  4. T, B, and NKT Cells in Systemic Inflammation in Obstructive Sleep Apnea 😴🩺
  5. Macrophage polarization in interstitial lung diseases 💔🫁
  6. D4+/CD25high/FoxP3+/CD127- regulatory T cells in bronchoalveolar lavage fluid of lung cancer patients 🫀💉
  7. Elevated regulatory T cells, surface and intracellular CTLA‐4 expression and interleukin‐17 in the lung cancer microenvironment in humans 🫀🧪
  8. Elevated Foxp3/CD8 ratio in lung adenocarcinoma metastatic lymph nodes resected by transcervical extended mediastinal lymphadenectomy 🔬💊
  9. Immunophenotype of t cells expressing programmed death-1 and cytotoxic T cell antigen-4 in early lung cancer: local vs. systemic immune response 🎗️🫁
  10. Fas-positive lymphocytes are associated with systemic inflammation in obstructive sleep Apnea syndrome 🛏️🔬

Conclusion:

Dr. Iwona Kwiecień is a highly capable researcher whose work has made substantial contributions to clinical immunology. Her ongoing focus on the immune responses in cancer offers significant potential for advancing cancer diagnostics and therapeutics. With a strong academic and research background, she is undoubtedly a strong candidate for the Best Researcher Award.